Medicine & Life Sciences
sec-butyl-propylacetamide
100%
Status Epilepticus
88%
Seizures
65%
valnoctamide
64%
Epilepsy
64%
Valproic Acid
37%
Anticonvulsants
35%
dipropylacetamide
32%
Pharmacokinetics
32%
Oxidative Stress
32%
Stereoisomerism
30%
Reactive Oxygen Species
28%
Temporal Lobe Epilepsy
25%
Antioxidants
19%
Brain
18%
Neurons
16%
NADPH Oxidases
16%
Topiramate
14%
Delayed-Action Preparations
13%
Drug Resistant Epilepsy
13%
Hippocampus
12%
N-(11-cyano-2,2,6a,6b,9,9,12a-heptmethyl-10,14-dioxo-1,3,4,5,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydro-2H-picen-4a-yl)-2-2-difluoropropionamide
12%
Organophosphates
11%
Pilocarpine
11%
sulforafan
10%
Genetic Therapy
10%
Protein Isoforms
10%
Pharmaceutical Preparations
10%
Deanol
9%
Paraoxon
9%
Astrocytes
9%
Kelch-Like ECH-Associated Protein 1
9%
NADPH Oxidase 2
8%
Dimethyl Fumarate
8%
Cannabidiol
8%
Carbamates
7%
Soman
7%
Brain Diseases
7%
HMGB1 Protein
7%
In Vitro Techniques
7%
Therapeutics
7%
Kainic Acid
7%
Endocannabinoids
6%
Neural Tube Defects
6%
Benzodiazepines
6%
Risperidone
6%
Self Administration
6%
Partial Epilepsy
6%
Animals
6%
Potassium Channels
6%
Chemistry
Reactive Oxygen Metabolite
20%
Oxidative Stress
18%
Valproic Acid
18%
Antioxidant Agent
11%
Sulforaphane
9%
Dimethyl Fumarate
8%
Intraperitoneal
7%
Neuroprotective
7%
Stereoisomer
6%
Anticonvulsant
6%
Disorder
6%
Marker
6%
Pharmacokinetics
5%